Present IconHave an Alzheimer's or MCI diagnosis?
Receive a free test by participating in our study →
NeuroAge Therapeutics logo

A personal commitment to fighting brain aging

Christin

NeuroAge was founded from a deep personal connection to fighting brain aging. Dr. Christin Glorioso's grandmother passed away from Alzheimer’s disease when she was a child. She witnessed the suffering that brought to her grandmother and to her loved ones. Since that time, she has had a lifelong commitment to creating better therapies to prevent and treat Alzheimer’s. Previously, Dr. Glorioso was a Scientist at MIT, Head of AI of TeachAids, and Chief Strategist of the Bakar Aging Research Institute at UCSF. She completed her MD and PhD in Neuroscience from the University of Pittsburgh and Carnegie Mellon Medical Scientist Training Program and her postdoctoral training at MIT.

Meet our team

Team

Yuriy _Golikov

Yuriy Golikov, M.S.

VP of Engineering

Sam_Lee

Sam Lee, MEng

AI Engineer

Stephen_Hubbard

Stephen Hubbard

Director of Business Development

Dariia_Valashenko

Dariia Valashenko

Clinical Administrator

Marah_Doria

Marah Doria

Programs and Operations Coordinator

Bhavna_Malladi

Bhavna Malladi, Neuroscience and Data Science

ML Engineer Intern

Meenu_Krishnakumar

Meenu Krishnakumar, MS in Computer Science

ML Engineer Intern

Advisors

Ronjon_Nag

Dr. Ronjon Nag, Ph.D

Founder R42 | Inventor | Adjunct Prof. in Genetics, Stanford Medicine

Matt_Kaeberlein

Dr. Matt Kaeberlein, Ph.D

CEO, Optispan Ventures

Joshua_Kuluva

Dr. Joshua Kuluva, M.D.

Neurologist and Psychiatrist, President of Piedmont Neuroscience Center, Director of TMS and TBI Programs

Lawrence_Tanenbaum

Dr. Lawrence Tanenbaum, M.D.

Board certified radiologist, former CTO of Radnet Imaging

Salah_Mahmoudi

Dr. Salah Mahmoudi, Ph.D

CEO of Reneu Bio, Ex-Pfizer, Ex-Alkahest